WilmerHale ’s executive compensation and employee benefits practice, led by Kim Wethly in Boston, advises employers, executives, and benefits providers on a range of compensation and benefits matters. The team handles equity and nonqualified compensation plans, ERISA and 401(k) issues, and compliance with SEC and IRS regulations. The firm’s expertise extends to advising multinational clients on cross-border compensation strategies and structuring employee benefits in corporate transactions. Wethly is noted for her experience in advising corporate boards and executives on compensation committees and incentive plans. Clients span various industries, including technology, financial services, and life sciences.
Legal 500 Editorial commentary
- Profile
Testimonials
Collated independently by Legal 500 research team.
‘Kimberly Wethly leads a team with deep and broad experience in advising public companies on compensation matters. Compensation at public companies has become increasingly complex and every public company needs sophisticated counsel like the team at WilmerHale.’
‘Kimberly Wethly is both extraordinarily well versed in executive compensation matters and adept at communicating complex topics.’
Key clients
- General Catalyst
- TechTarget Inc.
- Alcresta Therapeutics
- Sierra Space Corporation
- Eliem Therapeutics, Inc.
- Blue Apron Holdings, Inc.
- Decibel Therapeutics
- Seaport Therapeutics
Work highlights
- Represented TechTarget in its $1.6 Billion combination agreement with Informa Tech’s digital businesses.
- Represented Sierra Space in its $290 million Series B funding round.
- Represented Eliem Therapeutics, Inc. in its definitive merger agreement to acquire Tenet Medicines, Inc.
Lawyers
Practice head
Kim Wethly